NEWS

NEW FRONTIERS IN CANCER TREATMENT

ASGCT Poster Presentation: “Systematic identification of potent guide RNAs with minimal off-target activity for the CRISPR/Cas9 engineering of KSQ-001, and engineered Tumor Infiltrating Lymphocyte (eTIL™)”

Click to download PDF file.